CH622020A5 - - Google Patents
Download PDFInfo
- Publication number
- CH622020A5 CH622020A5 CH153980A CH153980A CH622020A5 CH 622020 A5 CH622020 A5 CH 622020A5 CH 153980 A CH153980 A CH 153980A CH 153980 A CH153980 A CH 153980A CH 622020 A5 CH622020 A5 CH 622020A5
- Authority
- CH
- Switzerland
- Prior art keywords
- formula
- hydrogen
- trihydroxy
- oxa
- trans
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA00752806A ZA752806B (en) | 1975-04-30 | 1975-04-30 | Novel 11-oxa-prostaglandin analogues derivatives thereof and methods for their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH622020A5 true CH622020A5 (it) | 1981-03-13 |
Family
ID=25568947
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH545676A CH623578A5 (it) | 1975-04-30 | 1976-04-30 | |
| CH153980A CH622020A5 (it) | 1975-04-30 | 1980-02-26 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH545676A CH623578A5 (it) | 1975-04-30 | 1976-04-30 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4133817A (it) |
| JP (1) | JPS51133264A (it) |
| AU (1) | AU501804B2 (it) |
| CA (1) | CA1084059A (it) |
| CH (2) | CH623578A5 (it) |
| DE (1) | DE2618861A1 (it) |
| GB (1) | GB1540443A (it) |
| ZA (1) | ZA752806B (it) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6395494B1 (en) | 1993-05-13 | 2002-05-28 | Neorx Corporation | Method to determine TGF-β |
| US5814660A (en) * | 1995-12-22 | 1998-09-29 | Alcon Laboratories, Inc. | 9-oxa prostaglandin analogs as ocular hypotensives |
| CA2236582C (en) | 1995-12-22 | 2004-08-17 | Alcon Laboratories, Inc. | Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
| US5866602A (en) * | 1995-12-22 | 1999-02-02 | Alcon Laboratories, Inc. | Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
| US6388128B1 (en) | 1998-10-05 | 2002-05-14 | Alcon Manufacturing, Ltd. | Stannane synthesis of prostanoids |
| US6441196B2 (en) | 2000-05-19 | 2002-08-27 | Alcon, Inc. | Processes and novel intermediates for 11-oxa prostaglandin synthesis |
-
1975
- 1975-04-30 ZA ZA00752806A patent/ZA752806B/xx unknown
-
1976
- 1976-04-22 AU AU13239/76A patent/AU501804B2/en not_active Expired
- 1976-04-29 DE DE19762618861 patent/DE2618861A1/de not_active Ceased
- 1976-04-29 US US05/681,742 patent/US4133817A/en not_active Expired - Lifetime
- 1976-04-29 CA CA251,454A patent/CA1084059A/en not_active Expired
- 1976-04-30 GB GB17811/76A patent/GB1540443A/en not_active Expired
- 1976-04-30 JP JP51049771A patent/JPS51133264A/ja active Pending
- 1976-04-30 CH CH545676A patent/CH623578A5/de not_active IP Right Cessation
-
1980
- 1980-02-26 CH CH153980A patent/CH622020A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU1323976A (en) | 1977-10-27 |
| CA1084059A (en) | 1980-08-19 |
| ZA752806B (en) | 1976-12-29 |
| GB1540443A (en) | 1979-02-14 |
| DE2618861A1 (de) | 1976-11-11 |
| US4133817A (en) | 1979-01-09 |
| CH623578A5 (it) | 1981-06-15 |
| AU501804B2 (en) | 1979-06-28 |
| JPS51133264A (en) | 1976-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH627725A5 (de) | Verfahren zur herstellung neuer prostaglandin-analoga mit primaerer alkoholgruppe am c-1. | |
| DE2223365C3 (de) | Prostansäurederivate, Verfahren zu ihrer Herstellung, solche Derivate enthaltende pharmazeutische und veterinäre Zusammensetzungen sowie Zwischenprodukte zur Herstellung dieser Derivate | |
| DE2840032C2 (de) | Prostaglandin-Analoge, Verfahren zu ihrer Herstellung, sowie diese enthaltende Arzneimittel | |
| EP0002234B1 (de) | Neue Prostacyclinderivate, ihre Herstellung und Anwendung | |
| CH622020A5 (it) | ||
| DE2322655C2 (de) | Prostaglandin F↓2↓↓α↓-ester, Verfahren zu deren Herstellung und deren Verwendung zur Reinigung von Prostaglandin-F↓2↓↓α↓ | |
| DE2315355A1 (de) | Verfahren zur herstellung von oximen | |
| DE2910474C2 (it) | ||
| DE2743283A1 (de) | Neue prostacyclin-analoga | |
| DE2945781A1 (de) | Prostacyclinzwischenprodukte und protacyclinanaloge | |
| DE2535343C2 (de) | 2-(6'-Carboxy-n-hexyl)-3-n-hexyl-cyclopentanole und -derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
| CH615659A5 (en) | Process for the preparation of novel 11,12-secoprostaglandins | |
| CH639950A5 (de) | Verfahren zur herstellung von neuen 13-thiaprostansaeurederivaten. | |
| DE2640692C3 (de) | Optisch aktive 5- (2-Carboxythiophen5-yl)-16phenoxy- a -tetranor- w tetranor-prostaglandine | |
| DE2440919A1 (de) | Prostaglandinanaloge, verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
| DE2731459A1 (de) | Cyclohexan-analoge vom prostaglandin-typ, verfahren zu deren herstellung und diese enthaltende zusammensetzungen | |
| DE3325677C2 (it) | ||
| DE2701455A1 (de) | Neue cyclopentanverbindungen | |
| CH615908A5 (en) | Process for the preparation of prostaglandines F-beta | |
| DE1593644C3 (it) | ||
| AT293361B (de) | Verfahren zur Herstellung von neuen β-Aminoacrylophenonen und deren Salzen | |
| DE2300367A1 (de) | Alkenyl- und alkinylsubstituierte xanthoncarbonsaeuren | |
| DE3541384A1 (de) | Prostacyclin-analoge | |
| AT364094B (de) | Verfahren zum herstellen von neuen pgfbeta-prostaglandinen | |
| DE2209039A1 (it) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |